NASDAQ · Financial Statements

Windward Bio Group AG (WWB) Revenue, Earnings & Financial Statements

$31.00 NASDAQ: WWB Market Cap $478.67M

Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)

Full income statement, balance sheet, and cash flow statement for Windward Bio Group AG (WWB), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Revenue and earnings of other Medical - Pharmaceuticals stocks

RPRX revenue $2.4BCORT revenue $761.0MLQDA revenue $158.0MPBH revenue $1.1BQUIT financialsHITI revenue $594.0MNSRX stockAll Medical - Pharmaceuticals stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
WWB Overview WWB Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.